Nov 7, 2025 · IgAN occurs when an abnormal protein damages the filtering unit (glomerulus) inside the kidneys. It is estimated that 20-40% of the people who have IgAN will develop end-stage kidney …

IgAN occurs when an abnormal protein damages the filtering unit (glomerulus) inside the kidneys. It is estimated that 20-40% of the people who have IgAN will develop end-stage kidney disease, which …

There is an urgent need to raise awareness about IgAN, including how it differs from other chronic kidney conditions, and to help assure more timely diagnoses. Nearly half of patients (48%) faced …

Visit www.igan.org for information, tools and support. • Find a kidney specialist you trust, someone who is knowledgeable about IgA Nephropathy and will work with your other health care providers to make …

The APRICOT study is an open-label, single-arm, multicenter Phase III clinical trial designed to evaluate the efficacy, pharmacokinetics, safety, and tolerability of iptacopan in pediatric patients aged 2 to …

As a part of our patient-centric mission focused on finding a cure for IgA Nephropathy and supporting IgAN Warriors, the resources below are designed to help equip and empower you through every part …

Many people with IgAN experience swelling in their hands and feet and protein and/or blood in their urine. Doctors typically recommend a low-sodium diet regardless of kidney function, but why?

There is no current cure for IgAN and that is why the IgA Nephropathy Foundation was founded. Since the disease varies from one person to another, there is no definite progression or course that the …

IgAN isn’t rare — it’s one of Australia’s most common and serious kidney diseases. More awareness, research, and support are urgently needed for patients and families.

When Bonnie Schneider’s son was diagnosed with IgAN at age 13, she had nowhere to turn for resources and patient support. She and her husband launched the Foundation from their kitchen …